Cvi Holdings, LLC Oragenics Inc Transaction History

Cvi Holdings, LLC

  • $11.5 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$0.36 - $0.64 $253,107 - $449,968
-703,075 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$0.46 - $0.6 $1.24 Million - $1.61 Million
-2,688,090 Reduced 79.27%
703,075 $345,000
Q1 2019

May 15, 2019
BUY
$0.57 - $1.05 $1.93 Million - $3.56 Million
3,391,165 New
3,391,165 $1.98 Million

About ORAGENICS INC

OGEN Quotes by TradingView
  • Ticker OGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 116,395,000
  • Market Cap $22.1M
  • Description
  • Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...
More about OGEN
Track This Portfolio

Track Cvi Holdings, LLC Portfolio

Follow Cvi Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cvi Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email